JAMA Internal Medicine

09/30/2025

💬 JAMA Perspective: The evaluation of moderate alcohol consumption on health is complex due to known harms of heavy drinking, potential benefits of low consumption, varying evidence quality, and biases.

https://ja.ma/3KrnaiN

09/29/2025

PREVENT risk equations identify fewer adults aged 40–59 as aspirin-eligible for primary ASCVD prevention than PCEs.

https://ja.ma/3IujYCr

09/29/2025

Special Communication: Doubling of early-onset cancer incidence since 1992 in US adults

09/27/2025

This Guide to Statistics and Methods explains how covariate-constrained randomization (CCR) enhances rigor in cluster randomized clinical trials. https://ja.ma/45JeSek

09/26/2025

The Patient Driven Payment Model was associated with increased coding intensity and Medicare expenditures in skilled nursing facilities, especially for medically complex patients, without affecting rehospitalization or mortality rates. https://ja.ma/4g6LUIL

09/25/2025

A digital quality measure for advanced-stage cancer diagnoses was associated with higher rates of missed diagnostic opportunities, with patients often experiencing diagnostic delays ranging from 1 to 20 months. https://ja.ma/3JGZuXk

09/24/2025

In adults with acute mild to moderate , metformin did not shorten recovery time compared to placebo, with similar median times to symptom resolution in both groups. https://ja.ma/4mg32xr

09/22/2025

In the latest episode of JAMA Internal Medicine Author Interviews, author Sammy Saab, MD, MPH, and guest expert Guadalupe Garcia-Tsao, MD, discuss metabolic-associated steatotic liver disease with Eve Rittenberg, MD.

Listen now:

Interview with Sammy Saab, MD, MPH, author of Targeting MASLD and MASH in the US Hispanic/Latino Population: A Review. Hosted by Eve Rittenberg, MD.

09/22/2025

This Review explores the factors that predispose Hispanic/Latino patients to metabolic dysfunction–associated steatotic liver disease and metabolic dysfunction–associated steatohepatitis.

https://ja.ma/47QgZ1j

09/22/2025

Cognitive behavioral therapy for was associated with improvements in insomnia severity, sleep efficiency, and sleep onset latency, with high treatment acceptability.

https://ja.ma/4naNT1x

09/20/2025

This case report describes a man in his 60s who presented with a 3-day history of low-grade, intermittent fever, myalgia, and headache, along with episodes of blurred vision and recurrent syncope. https://ja.ma/41yYomA

09/19/2025

Integrating lifestyle factors like diet and physical activity with receptor agonists is essential for managing symptoms, maintaining nutrition, preserving lean mass, and promoting regular physical activity. https://ja.ma/4n9MFmH